Carbetocin

Active ingredient description

Carbetocin selectively binds to oxytocin receptors in the smooth muscle of the uterus, stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions, and raises the tone of the uterus musculature.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
H01BB03
Carbetocin
H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BB Oxytocin and analogues
Discover more medicines within H01BB03

Medicines

Carbetocin is the active ingredient of these drugs:

Drug
Countries
DURATOBAL

Spain

DURATOCIN

Canada Hong Kong New Zealand Singapore

PABAL

Austria Finland France Ireland Lithuania

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
PABAL Solution for injection
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

88TWF8015Y - CARBETOCIN

CAS registry number

37025-55-1 - carbetocin

SNOMED-CT

425003007 - Carbetocin (substance)

Next: Usage